Skip to main content
. 2015 Dec 30;10(12):e0145258. doi: 10.1371/journal.pone.0145258

Fig 3. Distribution of Th1, Th2, Th17 and Treg subpopulations out of CD4+ T lymphocytes.

Fig 3

(A) PBMCs were stained with anti-CD4 PE-cy7, anti-CD25 APC, anti-IFN-γ FITC, anti-IL-17 PE, anti-IL-4 APC and anti-Foxp3 FITC. CD4+ T cells were gated for further analysis. (B) The proportion (%) of IFN-γ+/CD4+ T cells (C) IL-4+/CD4+ T cells (D) IL-17+/CD4+ T cells (E) CD25+FOXP3+/CD4+T cells in each patient group. * P<0.05 for each comparison. LTS, long term stable; CAD, chronic allograft dysfunction; ES, early stable; ESRD, end stage renal disease; HC, healthy control.